Cite
Morphoproteomics Identifies the Vitamin D Receptor as a Potential Therapeutic Partner in Alveolar Pneumocytes for COVID-19 Infected Patients.
MLA
Brown, Robert E., et al. “Morphoproteomics Identifies the Vitamin D Receptor as a Potential Therapeutic Partner in Alveolar Pneumocytes for COVID-19 Infected Patients.” Annals of Clinical and Laboratory Science, vol. 50, no. 5, Sept. 2020, pp. 699–700. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=33067219&authtype=sso&custid=ns315887.
APA
Brown, R. E., Wolf, D. A., & Tahseen, D. (2020). Morphoproteomics Identifies the Vitamin D Receptor as a Potential Therapeutic Partner in Alveolar Pneumocytes for COVID-19 Infected Patients. Annals of Clinical and Laboratory Science, 50(5), 699–700.
Chicago
Brown, Robert E, Dwayne A Wolf, and Danyal Tahseen. 2020. “Morphoproteomics Identifies the Vitamin D Receptor as a Potential Therapeutic Partner in Alveolar Pneumocytes for COVID-19 Infected Patients.” Annals of Clinical and Laboratory Science 50 (5): 699–700. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=33067219&authtype=sso&custid=ns315887.